Why is Gufic BioScience falling/rising?

As of 02-Jul, Gufic BioSciences Ltd is currently priced at 349.60, reflecting a decrease of 4.5, or 1.27%. The stock has underperformed its sector today by 1.35% and has experienced a consecutive decline over the last two days, resulting in a total drop of 3.9%. Over the past week, the stock has decreased by 0.40%, and in the last month, it has fallen by 4.59%. The company has reported negative results in the last two quarters, with a significant drop in net sales and a 62.3% decline in profit after tax compared to the previous four-quarter average. Additionally, the stock is trading below all its moving averages, indicating a bearish trend, and has seen a decrease in investor participation.
In the broader market context, the Sensex has increased by 0.79% over the past week, contrasting with Gufic BioSciences' negative performance. The company has underperformed the benchmark indices over various time frames, including a year-to-date return of -22.83% compared to the Sensex's 6.75%. Despite having a high return on capital employed and a strong ability to service debt, the stock's valuation appears expensive relative to its peers, further contributing to its downward trajectory. Overall, the combination of poor financial results, declining investor interest, and underperformance against the market has led to the stock's current decline.